Leerink Swann Downgrades Pharmasset (VRUS) to Market Perform; A Befitting End to a Remarkable Biotech Story
Go back to Leerink Swann Downgrades Pharmasset (VRUS) to Market Perform; A Befitting End to a Remarkable Biotech Story| Gilead Sciences (NASDAQ: GILD) | Delayed: 135.69 -0.08 (0.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $135.77 | 52 Week High | $108.63 | |||
| Open | $133.99 | 52 Week Low | $71.39 | |||
| Day High | $135.85 | P/E | 74.97 | |||
| Day Low | $133.30 | EPS | $1.81 | |||
| Volume | 248,419 | |||||
| Johnson & Johnson (NYSE: JNJ) | Delayed: 258.01 -1.79 (0.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $259.80 | 52 Week High | $126.07 | |||
| Open | $256.00 | 52 Week Low | $94.28 | |||
| Day High | $258.34 | P/E | 53.64 | |||
| Day Low | $255.26 | EPS | $4.81 | |||
| Volume | 295,175 | |||||
| Pharmasset, Inc. (AMEX: VRUS) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $137.81 | |||
| Open | $67.86 | 52 Week Low | $46.49 | |||
| Day High | $0.00 | P/E | 0.00 | |||
| Day Low | $0.00 | EPS | $-1.25 | |||
| Volume | 34,954 | |||||
